dr. goldberg2
Dr. Richard Goldberg Joins Real Brands' Board of Directors, Enters Consulting Agreement
May 07, 2024 08:30 ET | Real Brands Inc.
North Providence, RI, May 07, 2024 (GLOBE NEWSWIRE) -- Real Brands Inc. (OTCPK: RLBD) announced today that it has added Richard J. Goldberg, MD, MS, to its Board of Directors, and The Company has...
022122_Comprise_Social_Profile-Pic.jpg
Sierra West Group taps Comprise for website redesign project
May 01, 2024 10:00 ET | Comprise
BOULDER, Colo., May 01, 2024 (GLOBE NEWSWIRE) -- Comprise® today announced a partnership with Sierra West Group to improve the website and content marketing materials of one of the country’s leading...
YPrime CNS Survey - Key eCOA Attributes
New YPrime Report Highlights eCOA's Impact on CNS Trials
May 01, 2024 08:00 ET | Y-Prime, LLC
YPrime has released a new report, Insights into CNS Clinical Trials, which demonstrates to sponsors how eCOA can help streamline CNS research.
Picture1.png
VCI Global Announces 145% Revenue Growth for Fiscal Year 2023 Financial Results
April 30, 2024 08:33 ET | VCI Global Limited
VCIG achieved record revenue of $19.8M, up 145% YoY, with net income soaring to $7.2M, a 57% increase due to growth of its various business segments.
Full Logo - OKYO .jpg
OKYO Pharma Announces Upcoming Presentation of OK-101 Phase 2 Data for Dry Eye Disease at the Dry Horizons Symposium, a Partner Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
April 30, 2024 07:00 ET | OKYO Pharma LTD
LONDON and NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...
Table 1
Tiziana Life Sciences Announces Additional Clinical Improvements Among Multiple Sclerosis Patients in its Expanded Access Program
April 22, 2024 07:00 ET | Tiziana Life Sciences Ltd.
70% of Patients in the Expanded Access Program (EAP) Have Seen Measurable Clinical Improvement in Their Fatigue After Six Months of Follow-upAll Patients Have Either Stabilized or Improved on Nasal...
Logo_Anaqua-Color.png
Anaqua macht ausländische Patentanmeldungen zu einem strategischen Vorteil für IP-Profis
April 18, 2024 07:00 ET | Anaqua
BOSTON / MÜNCHEN, April 18, 2024 (GLOBE NEWSWIRE) -- Anaqua, der führende Anbieter von Innovations- und IP-Management-Technologien, kündigt die Weiterentwicklung seines Angebots für...
Logo_Anaqua-Color.png
アナクアが外国特許出願を戦略的アドバンテージに変える 機能・サービス強化を発表
April 18, 2024 07:00 ET | Anaqua
ボストン, April 18, 2024 (GLOBE NEWSWIRE) --...
Logo_Anaqua-Color.png
Anaqua transforme l’extension de brevets à l’international en avantage stratégique pour les professionnels de la PI
April 18, 2024 07:00 ET | Anaqua
BOSTON, 18 avr. 2024 (GLOBE NEWSWIRE) -- Anaqua, le leader des technologies de gestion de la propriété intellectuelle (PI) pour les entreprises, les conseils et les administrations, annonce...
Logo_Anaqua-Color.png
Anaqua Transforms Foreign Patent Filing into a Strategic Advantage for Intellectual Property Professionals
April 18, 2024 07:00 ET | Anaqua
Anaqua revolutionizes IP management with enhanced Foreign Filing in AQX®, empowering swift global protection decisions.